Evidence map›Paper›PMID 18804378›Full record

ArticleCurrent biology : CB2008

The Target of Rapamycin pathway antagonizes pha-4/FoxA to control development and aging.

Karyn L Sheaffer, Dustin L Updike, Susan E Mango

Open access · bronzeAbstract read
In one paragraph

Article in Current biology : CB, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 170 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Microorganisms · 2026
    Article
  5. Article
  6. Lactate promotes longevity through redox-driven lipid remodeling inbioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Biomolecules · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Live or death in cells: from micronutrition metabolism to cell fate.Frontiers in cell and developmental biology · 2023
    Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Karyn L SheafferDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Dustin L Updike
Susan E Mango
Huntsman Cancer Institute · USUniversity of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
DEVELOPMENTAL BIOLOGY TRAINING PROGRAMT32HD007491 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI James Alan Gagnon, Kristen M Kwan · 1995 to 2026
$8.0M
ORGANOGENESIS OF THE PHARYNX IN C ELEGANSR01GM056264 · NIGMS · UNIVERSITY OF UTAH · PI MANGO, SUSAN E · 1998 to 2010
$3.3M
Lipid Homeostasis in C. elegansR01DK070184 · NIDDK · UNIVERSITY OF UTAH · PI MANGO, SUSAN E · 2004 to 2007
$1.2M
NCI NIH HHS P30 CA042014NCI NIH HHS P30 CA42014NICHD NIH HHS T32 HD007491NIDDK NIH HHS R01 DK070184NIDDK NIH HHS R01DK070184NIGMS NIH HHS R01 GM056264NIGMS NIH HHS R01GM056264
6 · The paper itself

Abstract

backgroundFoxA factors are critical regulators of embryonic development and postembryonic life, but little is know about the upstream pathways that modulate their activity. C. elegans pha-4 encodes a FoxA transcription factor that is required to establish the foregut in embryos and to control growth and longevity after birth. We previously identified the AAA+ ATPase homolog ruvb-1 as a potent suppressor of pha-4 mutations.

resultsHere we show that ruvb-1 is a component of the Target of Rapamycin (TOR) pathway in C. elegans (CeTOR). Both ruvb-1 and let-363/TOR control nucleolar size and promote localization of box C/D snoRNPs to nucleoli, suggesting a role in rRNA maturation. Inactivation of let-363/TOR or ruvb-1 suppresses the lethality associated with reduced pha-4 activity. The CeTOR pathway controls protein homeostasis and also contributes to adult longevity. We find that pha-4 is required to extend adult lifespan in response to reduced CeTOR signaling. Mutations in the predicted CeTOR target rsks-1/S6 kinase or in ife-2/eIF4E also reduce protein biosynthesis and extend lifespan, but only rsks-1 mutations require pha-4 for adult longevity. In addition, rsks-1, but not ife-2, can suppress the larval lethality associated with pha-4 loss-of-function mutations.

conclusionsThe data suggest that pha-4 and the CeTOR pathway antagonize one another to regulate postembryonic development and adult longevity. We suggest a model in which nutrients promote TOR and S6 kinase signaling, which represses pha-4/FoxA, leading to a shorter lifespan. A similar regulatory hierarchy may function in other animals to modulate metabolism, longevity, or disease.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsLarvaLongevityNuclear ProteinsPhenotypePhosphotransferases (Alcohol Group Acceptor)RibonucleoproteinsRNARNA InterferenceTrans-ActivatorsCaenorhabditis elegans Proteinslet-363 protein, C elegansNuclear ProteinsPha-4 protein, C elegansPhosphotransferases (Alcohol Group Acceptor)RibonucleoproteinsRNATrans-Activators

Identifiers

PMID18804378
PMCPMC2615410
OpenAlexW2123754932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.